Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock
Older age is associated with worse outcomes in patients with cardiogenic shock complicating ST-elevation myocardial infarction (STEMI). However, significant heterogeneity exists in different age groups with respect to outcomes. Identification of factors that modulate age-related risk of death in pat...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2007-03, Vol.99 (6), p.793-796 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 796 |
|---|---|
| container_issue | 6 |
| container_start_page | 793 |
| container_title | The American journal of cardiology |
| container_volume | 99 |
| creator | Mehta, Rajendra H., MD, MS Califf, Robert M., MD Yang, Qinghong, MS Pieper, Karen S., MS White, Harvey D., DSc Ohman, E. Magnus, MD Harrington, Robert A., MD Granger, Christopher B., MD |
| description | Older age is associated with worse outcomes in patients with cardiogenic shock complicating ST-elevation myocardial infarction (STEMI). However, significant heterogeneity exists in different age groups with respect to outcomes. Identification of factors that modulate age-related risk of death in patients with cardiogenic shock may help clinical decision making and facilitate patient counseling. Accordingly, we evaluated 761 patients with STEMI who presented with cardiogenic shock and received fibrinolysis. We categorized patients into 3 age groups (80 mm Hg had substantial chance of recovery. In contrast, those with a systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min had 30-day death rates >90% even if they were young. In conclusion, our data suggest that, although elderly patients with cardiogenic shock have poor prognosis, presenting heart rate and systolic blood pressure provide important information to differentiate who may have greater chance of recovery. This information may help physicians in deciding treatment options for patients with cardiogenic shock and counseling them about their risks. |
| doi_str_mv | 10.1016/j.amjcard.2006.10.035 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70249121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914906023666</els_id><sourcerecordid>1238507021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-673210d719da5b1eeb61579d6a97c93ef55c124e7f45d19f778fd9b5b7f52cec3</originalsourceid><addsrcrecordid>eNqFkt9u0zAUxiMEYmPwCCALCe5S_CeOmxtQqTZWaRNoLeLScpyTzp0TF9uZlIfknXDWikm74cr20e_7zrE_Z9lbgmcEk_LTbqa6nVa-mVGMy1SbYcafZadkLqqcVIQ9z04xxjSvSFGdZK9C2KUjIbx8mZ0QwThmpTjN_qy6vdIRuRatehONsugSlI_oRkVAqm_QegzRWaPRV-tcg354CGHwgFyPbsCqaNImqRfbA37tfFTWxBEtOtdv0YWpvemdHaPR-cZDsk0mSQZ9DOiXibdooYfUa73Jzy3cHwyvRzfdbRpn1bfK64fq1DvJTLJ9EC4nxG2hT9Otb52-e529aJUN8Oa4nmU_L843y8v86vu31XJxletC8JiXglGCG0GqRvGaANQl4aJqSlUJXTFoOdeEFiDagjekaoWYt01V81q0nGrQ7Cz7ePDde_d7gBBlZ4IGa1UPbghSYFpUhJIEvn8C7tzg-zSbpAwzQRlhCeIHSHsXgodW7r3plB8lwXIKW-7kMWw5hT2VU9hJ9-5oPtQdNI-qY7oJ-HAEVNDKtl712oRHrsLzOS3KxH05cJDe7N6Al0GnfDQ0xoOOsnHmv6N8fuKgrUmxKHsHI4R_lyYyUInlevqZ08fEJaasLEv2F13v4iQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230372313</pqid></control><display><type>article</type><title>Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mehta, Rajendra H., MD, MS ; Califf, Robert M., MD ; Yang, Qinghong, MS ; Pieper, Karen S., MS ; White, Harvey D., DSc ; Ohman, E. Magnus, MD ; Harrington, Robert A., MD ; Granger, Christopher B., MD</creator><creatorcontrib>Mehta, Rajendra H., MD, MS ; Califf, Robert M., MD ; Yang, Qinghong, MS ; Pieper, Karen S., MS ; White, Harvey D., DSc ; Ohman, E. Magnus, MD ; Harrington, Robert A., MD ; Granger, Christopher B., MD</creatorcontrib><description>Older age is associated with worse outcomes in patients with cardiogenic shock complicating ST-elevation myocardial infarction (STEMI). However, significant heterogeneity exists in different age groups with respect to outcomes. Identification of factors that modulate age-related risk of death in patients with cardiogenic shock may help clinical decision making and facilitate patient counseling. Accordingly, we evaluated 761 patients with STEMI who presented with cardiogenic shock and received fibrinolysis. We categorized patients into 3 age groups (<60 years, n = 224; 60 to 75 years, n = 360; and ≥75 years, n = 177). Death at 30 days occurred in 118 patients <60 years of age (53%), 214 patients 60 to 75 years of age (59%), and 127 patients ≥75 years of age (72%) with cardiogenic shock. Factors associated with death (per 10-U change) on multivariable analysis were older age (odds ratio [OR] 1.43, 95% confidence interval [CI] 1.23 to 1.66), higher heart rate (OR 1.27, 95% CI 1.19 to 1.35), and lower systolic blood pressure (OR 1.32, 95% CI 1.23 to 1.41, c index 0.79). Important interactions were found with age, heart rate, and systolic blood pressure, suggesting that, although age was a strong independent predictor of death in patients with a heart rate ≤100 beats/min, it was less strongly related to death in patients with a heart rate >100 beats/min in whom prognosis was uniformly poor. Further, elderly patients with a systolic blood pressure >80 mm Hg had substantial chance of recovery. In contrast, those with a systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min had 30-day death rates >90% even if they were young. In conclusion, our data suggest that, although elderly patients with cardiogenic shock have poor prognosis, presenting heart rate and systolic blood pressure provide important information to differentiate who may have greater chance of recovery. This information may help physicians in deciding treatment options for patients with cardiogenic shock and counseling them about their risks.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2006.10.035</identifier><identifier>PMID: 17350367</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Age ; Age Distribution ; Age Factors ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Pressure ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Clinical outcomes ; Coronary heart disease ; Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care ; Female ; Fibrinolytic Agents - administration & dosage ; Heart ; Heart attacks ; Heart Rate ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Mortality ; Myocarditis. Cardiomyopathies ; Shock, Cardiogenic - drug therapy ; Shock, Cardiogenic - mortality ; Shock, Cardiogenic - physiopathology ; Streptokinase - administration & dosage ; Thrombolytic Therapy ; Tissue Plasminogen Activator - administration & dosage</subject><ispartof>The American journal of cardiology, 2007-03, Vol.99 (6), p.793-796</ispartof><rights>Elsevier Inc.</rights><rights>2007 Elsevier Inc.</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Mar 15, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-673210d719da5b1eeb61579d6a97c93ef55c124e7f45d19f778fd9b5b7f52cec3</citedby><cites>FETCH-LOGICAL-c475t-673210d719da5b1eeb61579d6a97c93ef55c124e7f45d19f778fd9b5b7f52cec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjcard.2006.10.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19088246$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17350367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehta, Rajendra H., MD, MS</creatorcontrib><creatorcontrib>Califf, Robert M., MD</creatorcontrib><creatorcontrib>Yang, Qinghong, MS</creatorcontrib><creatorcontrib>Pieper, Karen S., MS</creatorcontrib><creatorcontrib>White, Harvey D., DSc</creatorcontrib><creatorcontrib>Ohman, E. Magnus, MD</creatorcontrib><creatorcontrib>Harrington, Robert A., MD</creatorcontrib><creatorcontrib>Granger, Christopher B., MD</creatorcontrib><title>Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Older age is associated with worse outcomes in patients with cardiogenic shock complicating ST-elevation myocardial infarction (STEMI). However, significant heterogeneity exists in different age groups with respect to outcomes. Identification of factors that modulate age-related risk of death in patients with cardiogenic shock may help clinical decision making and facilitate patient counseling. Accordingly, we evaluated 761 patients with STEMI who presented with cardiogenic shock and received fibrinolysis. We categorized patients into 3 age groups (<60 years, n = 224; 60 to 75 years, n = 360; and ≥75 years, n = 177). Death at 30 days occurred in 118 patients <60 years of age (53%), 214 patients 60 to 75 years of age (59%), and 127 patients ≥75 years of age (72%) with cardiogenic shock. Factors associated with death (per 10-U change) on multivariable analysis were older age (odds ratio [OR] 1.43, 95% confidence interval [CI] 1.23 to 1.66), higher heart rate (OR 1.27, 95% CI 1.19 to 1.35), and lower systolic blood pressure (OR 1.32, 95% CI 1.23 to 1.41, c index 0.79). Important interactions were found with age, heart rate, and systolic blood pressure, suggesting that, although age was a strong independent predictor of death in patients with a heart rate ≤100 beats/min, it was less strongly related to death in patients with a heart rate >100 beats/min in whom prognosis was uniformly poor. Further, elderly patients with a systolic blood pressure >80 mm Hg had substantial chance of recovery. In contrast, those with a systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min had 30-day death rates >90% even if they were young. In conclusion, our data suggest that, although elderly patients with cardiogenic shock have poor prognosis, presenting heart rate and systolic blood pressure provide important information to differentiate who may have greater chance of recovery. This information may help physicians in deciding treatment options for patients with cardiogenic shock and counseling them about their risks.</description><subject>Age</subject><subject>Age Distribution</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Clinical outcomes</subject><subject>Coronary heart disease</subject><subject>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration & dosage</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart Rate</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Shock, Cardiogenic - drug therapy</subject><subject>Shock, Cardiogenic - mortality</subject><subject>Shock, Cardiogenic - physiopathology</subject><subject>Streptokinase - administration & dosage</subject><subject>Thrombolytic Therapy</subject><subject>Tissue Plasminogen Activator - administration & dosage</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkt9u0zAUxiMEYmPwCCALCe5S_CeOmxtQqTZWaRNoLeLScpyTzp0TF9uZlIfknXDWikm74cr20e_7zrE_Z9lbgmcEk_LTbqa6nVa-mVGMy1SbYcafZadkLqqcVIQ9z04xxjSvSFGdZK9C2KUjIbx8mZ0QwThmpTjN_qy6vdIRuRatehONsugSlI_oRkVAqm_QegzRWaPRV-tcg354CGHwgFyPbsCqaNImqRfbA37tfFTWxBEtOtdv0YWpvemdHaPR-cZDsk0mSQZ9DOiXibdooYfUa73Jzy3cHwyvRzfdbRpn1bfK64fq1DvJTLJ9EC4nxG2hT9Otb52-e529aJUN8Oa4nmU_L843y8v86vu31XJxletC8JiXglGCG0GqRvGaANQl4aJqSlUJXTFoOdeEFiDagjekaoWYt01V81q0nGrQ7Cz7ePDde_d7gBBlZ4IGa1UPbghSYFpUhJIEvn8C7tzg-zSbpAwzQRlhCeIHSHsXgodW7r3plB8lwXIKW-7kMWw5hT2VU9hJ9-5oPtQdNI-qY7oJ-HAEVNDKtl712oRHrsLzOS3KxH05cJDe7N6Al0GnfDQ0xoOOsnHmv6N8fuKgrUmxKHsHI4R_lyYyUInlevqZ08fEJaasLEv2F13v4iQ</recordid><startdate>20070315</startdate><enddate>20070315</enddate><creator>Mehta, Rajendra H., MD, MS</creator><creator>Califf, Robert M., MD</creator><creator>Yang, Qinghong, MS</creator><creator>Pieper, Karen S., MS</creator><creator>White, Harvey D., DSc</creator><creator>Ohman, E. Magnus, MD</creator><creator>Harrington, Robert A., MD</creator><creator>Granger, Christopher B., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20070315</creationdate><title>Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock</title><author>Mehta, Rajendra H., MD, MS ; Califf, Robert M., MD ; Yang, Qinghong, MS ; Pieper, Karen S., MS ; White, Harvey D., DSc ; Ohman, E. Magnus, MD ; Harrington, Robert A., MD ; Granger, Christopher B., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-673210d719da5b1eeb61579d6a97c93ef55c124e7f45d19f778fd9b5b7f52cec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Age</topic><topic>Age Distribution</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Clinical outcomes</topic><topic>Coronary heart disease</topic><topic>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration & dosage</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart Rate</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Shock, Cardiogenic - drug therapy</topic><topic>Shock, Cardiogenic - mortality</topic><topic>Shock, Cardiogenic - physiopathology</topic><topic>Streptokinase - administration & dosage</topic><topic>Thrombolytic Therapy</topic><topic>Tissue Plasminogen Activator - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehta, Rajendra H., MD, MS</creatorcontrib><creatorcontrib>Califf, Robert M., MD</creatorcontrib><creatorcontrib>Yang, Qinghong, MS</creatorcontrib><creatorcontrib>Pieper, Karen S., MS</creatorcontrib><creatorcontrib>White, Harvey D., DSc</creatorcontrib><creatorcontrib>Ohman, E. Magnus, MD</creatorcontrib><creatorcontrib>Harrington, Robert A., MD</creatorcontrib><creatorcontrib>Granger, Christopher B., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehta, Rajendra H., MD, MS</au><au>Califf, Robert M., MD</au><au>Yang, Qinghong, MS</au><au>Pieper, Karen S., MS</au><au>White, Harvey D., DSc</au><au>Ohman, E. Magnus, MD</au><au>Harrington, Robert A., MD</au><au>Granger, Christopher B., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2007-03-15</date><risdate>2007</risdate><volume>99</volume><issue>6</issue><spage>793</spage><epage>796</epage><pages>793-796</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Older age is associated with worse outcomes in patients with cardiogenic shock complicating ST-elevation myocardial infarction (STEMI). However, significant heterogeneity exists in different age groups with respect to outcomes. Identification of factors that modulate age-related risk of death in patients with cardiogenic shock may help clinical decision making and facilitate patient counseling. Accordingly, we evaluated 761 patients with STEMI who presented with cardiogenic shock and received fibrinolysis. We categorized patients into 3 age groups (<60 years, n = 224; 60 to 75 years, n = 360; and ≥75 years, n = 177). Death at 30 days occurred in 118 patients <60 years of age (53%), 214 patients 60 to 75 years of age (59%), and 127 patients ≥75 years of age (72%) with cardiogenic shock. Factors associated with death (per 10-U change) on multivariable analysis were older age (odds ratio [OR] 1.43, 95% confidence interval [CI] 1.23 to 1.66), higher heart rate (OR 1.27, 95% CI 1.19 to 1.35), and lower systolic blood pressure (OR 1.32, 95% CI 1.23 to 1.41, c index 0.79). Important interactions were found with age, heart rate, and systolic blood pressure, suggesting that, although age was a strong independent predictor of death in patients with a heart rate ≤100 beats/min, it was less strongly related to death in patients with a heart rate >100 beats/min in whom prognosis was uniformly poor. Further, elderly patients with a systolic blood pressure >80 mm Hg had substantial chance of recovery. In contrast, those with a systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min had 30-day death rates >90% even if they were young. In conclusion, our data suggest that, although elderly patients with cardiogenic shock have poor prognosis, presenting heart rate and systolic blood pressure provide important information to differentiate who may have greater chance of recovery. This information may help physicians in deciding treatment options for patients with cardiogenic shock and counseling them about their risks.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17350367</pmid><doi>10.1016/j.amjcard.2006.10.035</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2007-03, Vol.99 (6), p.793-796 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70249121 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Age Age Distribution Age Factors Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Pressure Cardiology Cardiology. Vascular system Cardiovascular Clinical outcomes Coronary heart disease Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care Female Fibrinolytic Agents - administration & dosage Heart Heart attacks Heart Rate Humans Intensive care medicine Male Medical sciences Middle Aged Mortality Myocarditis. Cardiomyopathies Shock, Cardiogenic - drug therapy Shock, Cardiogenic - mortality Shock, Cardiogenic - physiopathology Streptokinase - administration & dosage Thrombolytic Therapy Tissue Plasminogen Activator - administration & dosage |
| title | Impact of Initial Heart Rate and Systolic Blood Pressure on Relation of Age and Mortality Among Fibrinolytic-Treated Patients With Acute ST-Elevation Myocardial Infarction Presenting With Cardiogenic Shock |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T19%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Initial%20Heart%20Rate%20and%20Systolic%20Blood%20Pressure%20on%20Relation%20of%20Age%20and%20Mortality%20Among%20Fibrinolytic-Treated%20Patients%20With%20Acute%20ST-Elevation%20Myocardial%20Infarction%20Presenting%20With%20Cardiogenic%20Shock&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Mehta,%20Rajendra%20H.,%20MD,%20MS&rft.date=2007-03-15&rft.volume=99&rft.issue=6&rft.spage=793&rft.epage=796&rft.pages=793-796&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2006.10.035&rft_dat=%3Cproquest_cross%3E1238507021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230372313&rft_id=info:pmid/17350367&rft_els_id=S0002914906023666&rfr_iscdi=true |